HK Movers | XtalPi Stock Jumps 5% as Its Subsidiary Ailux Partners with Lilly on AI-Driven Bispecific Antibody Development

Reuters

Nov 06

XtalPi stock jumped over 5% on Thursday.

Shanghai Ailux Biotechnology Co., Ltd. (Ailux Shanghai), a wholly-owned subsidiary of XtalPi Holdings Ltd., has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of AI-driven bispecific antibodies for the treatment of various diseases.

Ailux is the biologics innovation arm of XtalPi, specializing in advanced biotherapeutics with AI-powered solutions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2581172879"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581172879\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581172879?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 09:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581172879","market":"hk","top_or_hot":-1,"title":"HK Movers | XtalPi Stock Jumps 5% as Its Subsidiary Ailux Partners with Lilly on AI-Driven Bispecific Antibody Development","media":"Reuters","content":"<html><head></head><body><p>XtalPi stock jumped over 5% on Thursday.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/e7cac4509222f4b727e28a3fa2e87c47\" title=\"\" tg-width=\"851\" tg-height=\"599\"/></p><p>Shanghai Ailux Biotechnology Co., Ltd. (Ailux Shanghai), a wholly-owned subsidiary of XtalPi Holdings Ltd., has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of AI-driven bispecific antibodies for the treatment of various diseases. </p><p>Ailux is the biologics innovation arm of XtalPi, specializing in advanced biotherapeutics with AI-powered solutions.</p><p></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK Movers | XtalPi Stock Jumps 5% as Its Subsidiary Ailux Partners with Lilly on AI-Driven Bispecific Antibody Development</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK Movers | XtalPi Stock Jumps 5% as Its Subsidiary Ailux Partners with Lilly on AI-Driven Bispecific Antibody Development\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-06 09:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>XtalPi stock jumped over 5% on Thursday.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/e7cac4509222f4b727e28a3fa2e87c47\" title=\"\" tg-width=\"851\" tg-height=\"599\"/></p><p>Shanghai Ailux Biotechnology Co., Ltd. (Ailux Shanghai), a wholly-owned subsidiary of XtalPi Holdings Ltd., has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of AI-driven bispecific antibodies for the treatment of various diseases. </p><p>Ailux is the biologics innovation arm of XtalPi, specializing in advanced biotherapeutics with AI-powered solutions.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02228","symbol_name":"晶泰控股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL5nYY9q:1","article_id":"2581172879","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581172879","pubTimestamp":1762393542,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":" XtalPi stock jumped over 5% on Thursday.Shanghai Ailux Biotechnology Co., Ltd. (Ailux Shanghai), a wholly-owned subsidiary of XtalPi Holdings Ltd., has announced a strategic collaboration with Eli...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02228":"晶泰控股","BK1617":"AI医疗","BK1141":"生命科学工具和服务"},"translate_title":"HK Movers|子公司Ailux与礼来合作开发人工智能驱动的双特异性抗体，XtalPi股价上涨5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02228":0.9},"content_text":"XtalPi stock jumped over 5% on Thursday.Shanghai Ailux Biotechnology Co., Ltd. (Ailux Shanghai), a wholly-owned subsidiary of XtalPi Holdings Ltd., has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of AI-driven bispecific antibodies for the treatment of various diseases. Ailux is the biologics innovation arm of XtalPi, specializing in advanced biotherapeutics with AI-powered solutions.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}